Singhe Hospitals PLC (COSE:SINH.N0000)

Singhe Hospitals Cash Flow Statement

Financials in millions LKR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	216.94	216.01	116.18	24.63	-12.73	16.41
Depreciation & Amortization	106.93	98.76	84.63	72.09	75.11	77.16
Other Amortization	1.37	1.37	1.75	1.61	1.38	1.35
Loss (Gain) From Sale of Assets	-1.54	-1.54	-	-	-	-
Loss (Gain) From Sale of Investments	-	-	0	0	-0.01	-0
Provision & Write-off of Bad Debts	-	-	-	0.75	0.06	0.04
Other Operating Activities	21.07	31.15	14.35	14.47	28.89	-0.83
Change in Accounts Receivable	-16.4	-2.37	5.06	-10.22	-6.23	10.8
Change in Inventory	4.41	3.64	-39.2	41.7	-25.41	-17.19
Change in Accounts Payable	17.43	3.51	52.81	-23.48	57.07	13.59
Change in Other Net Operating Assets	-101.65	-92.02	-3.26	-	-0.67	-1
Operating Cash Flow	248.57	258.52	232.32	121.55	117.46	100.32
Operating Cash Flow Growth	-3.69%	11.28%	91.14%	3.48%	17.08%	268.47%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-140.94	-126.59	-70.88	-46.39	-42.33	-61
Sale of Property, Plant & Equipment	1.8	1.57	-	-	-	-
Sale (Purchase) of Intangibles	-3.45	-3.31	-2.4	-6.99	-0.82	-0.46
Investment in Securities	-45.21	-76.05	-54.18	-1.9	-12	-
Other Investing Activities	-72.91	-77.31	-23.74	1.5	-7.79	-29.15
Investing Cash Flow	-260.7	-281.69	-151.21	-53.78	-62.94	-90.61

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Issued	-	85.59	30.46	-	12.67	31.49
Total Debt Issued	83.37	85.59	30.46	-	12.67	31.49
Long-Term Debt Repaid	-	-47.13	-70.82	-46.89	-40.62	-36.59
Net Debt Issued (Repaid)	30.78	38.46	-40.36	-46.89	-27.95	-5.1
Other Financing Activities	0	-	-	-	-	-
Financing Cash Flow	30.78	38.46	-40.36	-46.89	-27.95	-5.1

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Miscellaneous Cash Flow Adjustments	-	-	-	-	0	-
Net Cash Flow	18.65	15.29	40.75	20.89	26.57	4.61

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	107.63	131.92	161.44	75.16	75.13	39.32
Free Cash Flow Growth	-37.63%	-18.28%	114.79%	0.04%	91.07%	2632.35%
Free Cash Flow Margin	5.35%	6.85%	10.71%	5.91%	7.01%	3.92%
Free Cash Flow Per Share	0.25	0.31	0.37	0.17	0.17	0.09
Levered Free Cash Flow	59.66	83.94	141.69	57.21	75.57	36.82
Unlevered Free Cash Flow	77.55	101.14	160.68	91.67	114.05	58.01

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	18.64	17.54	22.29	49.31	64.85	35.89
Cash Income Tax Paid	59.3	50.66	16.87	5.43	-	-
Change in Working Capital	-96.2	-87.23	15.41	7.99	24.76	6.2

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 3, 2026

Data Sources Report a data error